Releases
Northwest Biotherapeutics to Present DCVax-L Survival Data at BNOS
Dr. Marnix Bosch, Chief Technical Officer at Northwest Biotherapeutics, is set to present findings on the survival benefits of DCVax-L at the British Neuro-Oncology Society Annual Meeting. The session, scheduled for July 3 in the UK, centers on the application of propensity score matching to evaluate patient outcomes.